Everand Logo

Welcome to Everand!

  • STAT

    Teva reaches $85 million settlement on eve of opioid trial in Oklahoma

    On the eve of a closely watched trial, Teva agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating…
    by Ed Silverman May 26, 2019 2 minutes
    A Teva Pharmaceutical facility building in Neot Hovav, Israel.

    On the eve of a closely watched trial, Teva Pharmaceutical () agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating the benefits of its opioid painkillers and downplaying addictive risks that led doctors to

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
    More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
    Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.

    Related Books & Audiobooks